Table 2 Participating Practice Characteristics Overall and by Cost of FIT (Known, Unknown)

Total N

84

(100)

40

(100)

44

(100)

 Solo/partnership (1, 2)

10

(12)

8

(20)

2

(5)

0.031^a

 Small to medium (3–10)

51

(61)

25

(63)

26

(59)

 Large (> 10)

23

(27)

7

(18)

16

(36)

 Frontier

10

(12)

6

(15)

4

(9)

0.61^a

 Rural

41

(49)

20

(50)

21

(48)

 Urban

33

(39)

14

(35)

19

(43)

 Laboratory

47

(57)

17

(43)

30

(71)

0.001^a

 Vendor

25

(30)

20

(50)

5

(12)

 Health System

10

(12)

3

(8)

7

(17)

 Number of patient visits per week, mean (min-max)

427

(32–5250)

314

(32–1200)

554

(105–5250)

0.07^b

 Percent of patient panel covered by Medicaid/CHIP/OHP, mean (min-max)

30

(2–85)

30

(2–75)

30

(5–85)

0.93^b

 Current CRC screening rate, mean (min-max)

59

(10–97)

56

(23–85)

62

(10–97)

0.14^b

 Number of QI projects related to CRC screening in past 12 months, mean (min-max)

1

(0–6)

1

(0–3)

1

(0–6)

0.86^b

 CRC improvement as priority in year ahead (1 no priority, 10 highest priority), mean (min-max)

8

(1–10)

8

(1–10)

8

(5–10)

0.74^b

 FIT/FOBT

7

(8)

3

(8)

4

(9)

0.96^a

 Colonoscopy

10

(12)

5

(13)

5

(11)

Both (colonoscopy & FIT/FOBT)

67

(80)

32

(80)

35

(80)

Preference for FIT/FOBT (1 = hate, 10 = love), mean (min-max)

7

(1–10)

7

(1–10)

7

(3–10)

0.18^b